Rheumatology Doctors in Fort Collins, CO Accepting Medicare

4 Rheumatology doctors found. Showing 1 - 4

Fred H Meyer, M.D. Internal Medicine - Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 219 S Sunset St, Fort Collins, CO 80521 Phone: 970-224-2156    Fax: 970-482-6936

Daniel Muller, MD PHD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2121 E Harmony Rd, Suite 230, Fort Collins, CO 80528 Phone: 970-350-2433    Fax: 970-593-9731

Stephen D Holt, M.D. Internal Medicine - Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 2121 E Harmony Rd, Suite 360, Fort Collins, CO 80528 Phone: 970-267-9799    Fax: 970-267-9559

Michael Samir Thakor, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2121 E Harmony Rd, Ste 361, Fort Collins, CO 80528 Phone: 970-267-9799    Fax: 970-267-9559

News Archive

Study finds simple solution to common bowel issues

Most people aren't eager to talk about how to improve bowel movements, but researchers at The Ohio State University Wexner Medical Center found the solution to common bowel issues may be as simple as boosting your feet on a stool.

PDS joins Dell's PartnerDirect program as EA Certified Partner

Professional Data Systems, a leading medical IT service provider, today announced it has joined Dell's PartnerDirect program as an Enterprise Architecture Certified Partner. Dell Certified Partnerships are granted only to select vendors who have met specific sales, customer service and training requirements. Dell has recognized PDS' proficiency in building solutions to meet the needs of their clients and their commitment to understanding the technology that Dell offers.

Nearly half of adults with mood disorders experience chronic pain, survey finds

In a survey of adults with anxiety or a mood disorder like depression or bipolar disorder, about half reported experiencing chronic pain, according to researchers at Columbia University's Mailman School of Public Health.

Promedior initiates PRM-151 Phase 2a clinical study in prevention of scarring post glaucoma filtration surgery

Promedior, Inc., a clinical stage biotechnology company developing novel therapies to treat fibrotic and inflammatory diseases, announced today that it has initiated a Phase 2a clinical study of PRM-151 to evaluate the efficacy, safety, and tolerability of PRM-151 in preventing post-surgical scarring in glaucoma patients following glaucoma filtration surgery. There currently are no approved drugs for preventing post-surgical scarring in glaucoma, and there are no approved anti-fibrotic drug therapies in the U.S. or Europe for any fibrotic disease.

Examining the infinitesimal - new approach to microscopy

A new approach to microscopy is opening up the wonders of the molecular world, allowing researchers to examine organic molecules and delicate crystals as they grow, atom by atom. Dr Andrew Humhpris, co-founder of the original technology and now Chief Technology Officer of Infinitesima, explains how this University spin-out has turned into a leading-edge company.

Read more Medical News

› Verified 1 days ago